In this edition of our newsletter, we are glad to share a recap of the most significant achievements in gut microbiome science in 2018, a year with the highest number of scientific papers published on this topic in the past two decades. You will also find a new scoping review on how non-medicinal therapies such as diet, exercise and psychotherapy should be used as an adjunctive treatment in the management of inflammatory bowel disease (IBD).
Next up is another review showing how the microbiome can be considered a therapeutical target for treating inflammatory diseases such as allergies. Also in this newsletter, a new study has found the interindividual variation in human gut microbiome composition outweighs the effect of dietary proteins and saturated fats.
Finally, we have a new article that concludes that the probiotic Bifidobacterium pseudocatenulatum CECT 7765 restores some of the neurochemical and behavioral changes found in diet-induced obese mice.
The GMFH publishing team